Ready to ask questions or get a product demo?

Understanding the New Breakthroughs in Weight Loss and Diabetes Care

The mounting popularity of GLP-1 therapies is changing how people – and the healthcare system – address type 2 diabetes and obesity care. This distinguished panel of clinical leaders will share what they believe must be contemplated when healthcare leaders are making precise benefit decisions, despite having no historical parallel to the situation we currently face with GLP-1s.

Watch the full session below.

Meet your speakers

Shealynn Buck , MD

Shealynn Buck , MD

Chief Medical Officer, Lockton

Robert Gabbay , MD, PhD, FACP

Robert Gabbay , MD, PhD, FACP

Chief Scientific and Medical Officer, American Diabetes Association

Timothy Law , DO, MBA

Timothy Law , DO, MBA

Chief Medical Officer, Highmark Health

Vidya Raman-Tangella

Vidya Raman-Tangella

Chief Medical Officer, Teladoc Health

Related Insights

Explore more Forum content